Journalist @ApexOnco. The Wolverine Of Biotech / Mr ASH. Never paid for a blue tick. Interested in: oncology. Not interested in: what stock you bought today.
Joined October 2012
- Tweets 28,970
- Following 285
- Followers 32,634
- Likes 3,504
5,287 Photos and videos
Jun 10
2
1
12
4,955
Jun 11
$SMMT pulled its proposed $500M offering "due to market conditions"
sec.gov/ix?doc=/Archives/edg…
1
10
5,131
Jun 11
When @JacobPlieth last wrote about $ELVN, the 80mg dose wasn't looking great, and now it's all about the 80mg dose? apexonco.com/different-dosin…
3
13
6,768
Jun 11
God bless the NCI! Remember $RHHBY effectively gave up testing Tecentriq in colorectal after Imblaze-370 failed in 2018 gene.com/media/press-release…
1
12
4,329
Jun 9
2
15
7,515
Jun 9
$NUVL was always an acquisition target, but I didn't have $GSK on my bingo card otp.tools.investis.com/gener…
23
4,325
Jun 8
$JNJ acquiring a pan-KRAS degrader via Firefly Bio for $1B
businesswire.com/news/home/2…
1
3
25
13,947
Jun 8
$NRIX just got $700m up front for bexo from $RHHBY. Deal includes expansion into immunology, neurology & MS
8 Dec 2025
$NRIX 23% surprises me. I thought the #ASH25 data showed $ONC to be better on efficacy (with caveats), albeit worse on safety. My earlier take on @ApexOnco -> oncologypipeline.com/apexonc…
3
2
27
12,396
Jun 2
5
4
21
14,645
Jun 2
Is Avencell basically Bellicum 2.0? "Switchable" Car-T, anti-CD123, albeit allogeneic #EHA2026
1
2
2,454
Jun 3
Actually, no: Avencell appears to be Unum 2.0 (I'm sure @PDRennert remembers how that worked out). Non-targeting Car "soluble" linking thingy with ScFv
1
4
1,862
Apr 30
$AZN Serena-6 immature OS curves as revealed at the adcom. Not sure we've seen these before.
3
5
31
15,014
Jun 3
1
2
8
3,264
Jun 2
3
1,607